Workflow
TriplePoint Venture Growth(TPVG)
icon
Search documents
TriplePoint Venture Growth(TPVG) - 2023 Q1 - Earnings Call Transcript
2023-05-04 00:40
TriplePoint Venture Growth (NYSE:TPVG) Q1 2023 Earnings Conference Call May 3, 2023 5:00 PM ET Company Participants Jim Labe – Chief Executive Officer and Chairman Sajal Srivastava – President and Chief Investment Officer Chris Mathieu – Chief Financial Officer Conference Call Participants Finian O'Shea – Wells Fargo Crispin Love – Piper Sandler Kevin Fultz – JMP Securities Ryan Lynch – KBW Casey Alexander – Compass Point Christopher Nolan – Ladenburg Thalmann Operator Good afternoon, ladies and gentlemen, ...
TriplePoint Venture Growth(TPVG) - 2023 Q1 - Quarterly Report
2023-05-03 21:08
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________________________________________________ Form 10-Q ________________________________________________________________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31 ...
TriplePoint Venture Growth(TPVG) - 2022 Q4 - Earnings Call Transcript
2023-03-01 23:40
Financial Data and Key Metrics Changes - The company generated net investment income (NII) of $0.58 per share, exceeding the quarterly distribution of $0.37, with an 8% increase in distribution to $0.40 per share [5][36] - Total investment income increased by 37% year-over-year to $34.9 million for Q4 and reached a record $119.4 million for the full year [30][31] - NII increased by 55% year-over-year to $20.5 million for Q4 and $63.6 million for the full year [34][30] Business Line Data and Key Metrics Changes - The investment portfolio reached nearly $1 billion, marking a record increase for the full year [10][17] - The weighted average portfolio yield at origination increased to 15.4% in Q4 from 14.5% in Q3 2022, with a full-year yield of 14.7% [20][31] - The company signed $221 million of term sheets and closed $105 million of debt commitments in Q4, with a record $2 billion of term sheets signed for the full year [18][19] Market Data and Key Metrics Changes - Venture capital fundraising was exceptionally strong in 2022, with $163 billion closed across 769 funds, setting an annual record [8] - The venture capital investment activity dropped significantly, with Q4 seeing only 936 deals closed for a total of $1.35 billion, the lowest quarterly deal value since Q2 2018 [6][7] Company Strategy and Development Direction - The company continues to focus on investing in attractive growth-stage companies backed by select venture capital investors, emphasizing quality over quantity in a volatile market [12][17] - The strategy includes maintaining a diversified portfolio and leveraging existing relationships with venture capital partners to support portfolio companies [29][12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the outlook for many portfolio companies, particularly in sectors like robotics and cybersecurity, despite macroeconomic challenges [11][12] - The company anticipates continued demand for venture-lending solutions and expects investment momentum to pick up in the second half of 2023 [8][17] Other Important Information - The company reported a cumulative net loss rate of under 2% of cumulative commitments since inception, with a notable write-off of Medly Health due to operational irregularities [15][16] - The total net asset value was $420 million or $11.88 per share as of year-end, impacted by a special distribution [35][36] Q&A Session Summary Question: What is the liquidity situation of portfolio companies? - Approximately 85% of portfolio companies have more than six months of cash runway, with over 60% having more than 12 months [40][41] Question: What are the current leverage levels and targets? - The current leverage ratio is 1.36 times gross and 1.22 times net, within the acceptable range of 1.2 to 1.4 [42][43] Question: How did Medly Health impact the portfolio? - Medly was placed on non-accrual status, impacting the portfolio yield, and the company confirmed all Medly investments are off the books [46][49] Question: Are portfolio companies experiencing down rounds? - Yes, some companies are facing down rounds, but there are also up rounds occurring, indicating a mixed environment [54] Question: What lessons were learned from the Medly situation? - The company acknowledged that every credit situation is a learning experience, and while there were no clear indicators of impropriety, they will continue to analyze business plans and ratios [60][61]
TriplePoint Venture Growth(TPVG) - 2022 Q4 - Annual Report
2023-03-01 21:43
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________________________________________________ Form 10-K ________________________________________________________________________________________________________________________________________________ (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 202 ...
TriplePoint Venture Growth(TPVG) - 2022 Q3 - Earnings Call Transcript
2022-11-02 23:35
TriplePoint Venture Growth (NYSE:TPVG) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants James Labe - Chairman and CEO Sajal Srivastava - President and Chief Investment Officer Christopher Mathieu - CFO Conference Call Participants Finian O'Shea - Wells Fargo Securities LLC Paul Johnson - KBW Christopher Nolan - Ladenburg Thalmann Operator Good afternoon, ladies and gentlemen. Welcome to the TriplePoint Venture Growth BDC Corp. Third Quarter 2022 Earnings Conference Call. At ...
TriplePoint Venture Growth(TPVG) - 2022 Q3 - Quarterly Report
2022-11-02 20:57
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________________________________________________ Form 10-Q ________________________________________________________________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBE ...
TriplePoint Venture Growth(TPVG) - 2022 Q2 - Earnings Call Transcript
2022-08-04 00:56
TriplePoint Venture Growth (NYSE:TPVG) Q2 2022 Earnings Conference Call August 3, 2022 5:00 PM ET Company Participants James Labe - Chairman and Chief Executive Officer Sajal Srivastava - President and Chief Investment Officer Christopher Mathieu - Chief Financial Officer Conference Call Participants Finian O'Shea - Wells Fargo Securities LLC Crispin Love - Piper Sandler & Co. Kevin Fultz - JMP Securities Casey Alexander - Compass Point Research & Trading LLC Christopher Nolan - Ladenburg Thalmann Ryan Lync ...
TriplePoint Venture Growth(TPVG) - 2022 Q2 - Quarterly Report
2022-08-03 20:27
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________________________________________________ Form 10-Q ________________________________________________________________________________________________________________________________________________ (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, ...
TriplePoint Venture Growth(TPVG) - 2022 Q1 - Earnings Call Presentation
2022-05-13 03:00
| --- | --- | --- | --- | --- | --- | |-------|-------|--------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Investor Presentation | | | | | | | Q u a r t e r E n d e d M a r c h 3 1 , 2022 M a y 4 , 2 022 | | | | | | | w w w. t p v g . c o m | | | | | | | | | | | Forward Looking Statements Some of the statements in this presentation constitute forward-looking statements, which relate ...
TriplePoint Venture Growth(TPVG) - 2022 Q1 - Earnings Call Transcript
2022-05-05 01:10
TriplePoint Venture Growth (NYSE:TPVG) Q1 2022 Earnings Conference Call May 4, 2022 5:00 PM ET Company Representatives Jim Labe - Chief Executive Officer, Chairman of the Board Sajal Srivastava - President, Chief Investment Officer Chris Mathieu - Chief Financial Officer Conference Call Participants Finian O’Shea - Wells Fargo Securities Christopher Nolan - Ladenburg Thalmann Kevin Fultz - JMP Securities Crispin Love - Piper Sandler Casey Alexander - Compass Point Ryan Lynch - KBW Operator Good afternoon, l ...